Table 3

VEEG overview

VariableTLE, n=74LTLE, n=43RTLE, n=31P
VEEG duration (median, IQR), days5 (4–5)5 (4–5)5 (4–5)p=0.8*
Number of seizures (median, IQR)2 (1–4)2 (1–3)2 (1–4)p=0.8*
Diurnal seizures (median, IQR)1 (1–2)1.5 (1–2)1 (0–2)p=0.5*
Nocturnal seizures (median, IQR)0 (0–1)1 (0–1)1 (0–2)p=0.2*
Seizures during wakefulness (median, IQR)1 (1–2)1 (1–2)1 (0–2)p=0.8*
Seizures during sleep (median, IQR)1 (0–1)1 (0–1)1 (0–2)p=0.5*
Patients with seizures during wakefulness only, n (%)30 (40.5%)22 (51.1%)8 (25.8%)p=0.2†
Patients with seizures during sleep only, n (%)8 (10.8%)4 (9.3%)4 (12.9%)
Patients with diurnal seizures only, n (%)29 (39.1%)19 (44.1%)10 (32.2%)p=0.2†
Patients with nocturnal seizures only, n (%)13 (18.3%)6 (13.9)7 (22.5%)
Seizures distribution, n (%)
 From 24:00 to 04:0022 (11.3%)11 (9.3%)11 (14.4%)p=0.008‡
 From 04:00 to 08:0028 (14.4%)12 (10.1%)16 (21.5%)
 From 08:00 to 12:0045 (23.2%)32 (27.1%)13 (17.1%)
 From 12:00 to 16:0056 (28.9%)36 (20.5%)20 (26.32)
 From 16:00 to 20:0021 (10.8%)14 (11.8%)7 (9.2%)
 From 20:00 to 24:0022 (11.3%)13 (11%)9 (11.85)
  • bold values means statistically significant difference.

  • *Unpaired T test.

  • †Fisher test.

  • ‡χ2 test.

  • LTLE, left temporal lobe epilepsy; RTLE, right temporal lobe epilepsy; TLE, temporal lobe epilepsy.